Is SBC Medical Group Holdings, Inc. overvalued or undervalued?

As of 13 August 2025, the valuation grade for SBC Medical Group Holdings, Inc. moved from fair to attractive, indicating a positive shift in its perceived value. The company appears undervalued based on its current metrics, with a P/E ratio of 11.684, an EV to EBITDA ratio of 4.9677, and a price to book value that suggests a favorable comparison to its peers.
In comparison to its industry, SBC Medical Group Holdings, Inc. is positioned favorably against competitors such as the average industry P/E, which typically reflects higher valuations. Notably, while the company has experienced a year-to-date return of -16.37%, it has outperformed the S&P 500 over the past week and month, with returns of 3.56% and 9.67%, respectively, suggesting a potential rebound in investor sentiment.